624 related articles for article (PubMed ID: 28196852)
21. INPP4B Is a Tumor Suppressor in the Context of PTEN Deficiency.
Vo TT; Fruman DA
Cancer Discov; 2015 Jul; 5(7):697-700. PubMed ID: 26152921
[TBL] [Abstract][Full Text] [Related]
22. PTEN Regulates PI(3,4)P
Malek M; Kielkowska A; Chessa T; Anderson KE; Barneda D; Pir P; Nakanishi H; Eguchi S; Koizumi A; Sasaki J; Juvin V; Kiselev VY; Niewczas I; Gray A; Valayer A; Spensberger D; Imbert M; Felisbino S; Habuchi T; Beinke S; Cosulich S; Le Novère N; Sasaki T; Clark J; Hawkins PT; Stephens LR
Mol Cell; 2017 Nov; 68(3):566-580.e10. PubMed ID: 29056325
[TBL] [Abstract][Full Text] [Related]
23. INPP4B: the new kid on the PI3K block.
Agoulnik IU; Hodgson MC; Bowden WA; Ittmann MM
Oncotarget; 2011 Apr; 2(4):321-8. PubMed ID: 21487159
[TBL] [Abstract][Full Text] [Related]
24. Epigenetic inactivation of inositol polyphosphate 4-phosphatase B (INPP4B), a regulator of PI3K/AKT signaling pathway in EBV-associated nasopharyngeal carcinoma.
Yuen JW; Chung GT; Lun SW; Cheung CC; To KF; Lo KW
PLoS One; 2014; 9(8):e105163. PubMed ID: 25126743
[TBL] [Abstract][Full Text] [Related]
25. Statin induces inhibition of triple negative breast cancer (TNBC) cells via PI3K pathway.
Park YH; Jung HH; Ahn JS; Im YH
Biochem Biophys Res Commun; 2013 Sep; 439(2):275-9. PubMed ID: 23973711
[TBL] [Abstract][Full Text] [Related]
26. Calycosin inhibits triple-negative breast cancer progression through down-regulation of the novel estrogen receptor-α splice variant ER-α30-mediated PI3K/AKT signaling pathway.
Li Y; Hu S; Chen Y; Zhang X; Gao H; Tian J; Chen J
Phytomedicine; 2023 Sep; 118():154924. PubMed ID: 37393829
[TBL] [Abstract][Full Text] [Related]
27. Preferential killing of PTEN-null myelomas by PI3K inhibitors through Akt pathway.
Zhang J; Choi Y; Mavromatis B; Lichtenstein A; Li W
Oncogene; 2003 Sep; 22(40):6289-95. PubMed ID: 13679867
[TBL] [Abstract][Full Text] [Related]
28. An integrative analysis of PIK3CA mutation, PTEN, and INPP4B expression in terms of trastuzumab efficacy in HER2-positive breast cancer.
Sueta A; Yamamoto Y; Yamamoto-Ibusuki M; Hayashi M; Takeshita T; Yamamoto S; Iwase H
PLoS One; 2014; 9(12):e116054. PubMed ID: 25542038
[TBL] [Abstract][Full Text] [Related]
29. PTEN regulation, a novel function for the p85 subunit of phosphoinositide 3-kinase.
Barber DF; Alvarado-Kristensson M; González-García A; Pulido R; Carrera AC
Sci STKE; 2006 Nov; 2006(362):pe49. PubMed ID: 17119157
[TBL] [Abstract][Full Text] [Related]
30. PTEN and Other PtdIns(3,4,5)P
Csolle MP; Ooms LM; Papa A; Mitchell CA
Int J Mol Sci; 2020 Dec; 21(23):. PubMed ID: 33276499
[TBL] [Abstract][Full Text] [Related]
31. The INPP4B Tumor Suppressor Modulates EGFR Trafficking and Promotes Triple-Negative Breast Cancer.
Liu H; Paddock MN; Wang H; Murphy CJ; Geck RC; Navarro AJ; Wulf GM; Elemento O; Haucke V; Cantley LC; Toker A
Cancer Discov; 2020 Aug; 10(8):1226-1239. PubMed ID: 32513774
[TBL] [Abstract][Full Text] [Related]
32. Phosphoinositide 3-kinase and INPP4B in human breast cancer.
Bertucci MC; Mitchell CA
Ann N Y Acad Sci; 2013 Mar; 1280():1-5. PubMed ID: 23551093
[TBL] [Abstract][Full Text] [Related]
33. PTEN suppresses breast cancer cell growth by phosphatase activity-dependent G1 arrest followed by cell death.
Weng LP; Smith WM; Dahia PL; Ziebold U; Gil E; Lees JA; Eng C
Cancer Res; 1999 Nov; 59(22):5808-14. PubMed ID: 10582703
[TBL] [Abstract][Full Text] [Related]
34. Detection of PIK3/AKT pathway in Moroccan population with triple negative breast cancer.
Jouali F; Marchoudi N; Talbi S; Bilal B; El Khasmi M; Rhaissi H; Fekkak J
BMC Cancer; 2018 Sep; 18(1):900. PubMed ID: 30227836
[TBL] [Abstract][Full Text] [Related]
35. PTEN expression causes feedback upregulation of insulin receptor substrate 2.
Simpson L; Li J; Liaw D; Hennessy I; Oliner J; Christians F; Parsons R
Mol Cell Biol; 2001 Jun; 21(12):3947-58. PubMed ID: 11359902
[TBL] [Abstract][Full Text] [Related]
36. Reconstitution of the mammalian PI3K/PTEN/Akt pathway in yeast.
Rodríguez-Escudero I; Roelants FM; Thorner J; Nombela C; Molina M; Cid VJ
Biochem J; 2005 Sep; 390(Pt 2):613-23. PubMed ID: 15913452
[TBL] [Abstract][Full Text] [Related]
37. Class I PI3-kinase or Akt inhibition do not impair axonal polarization, but slow down axonal elongation.
Diez H; Benitez MJ; Fernandez S; Torres-Aleman I; Garrido JJ; Wandosell F
Biochim Biophys Acta; 2016 Nov; 1863(11):2574-2583. PubMed ID: 27421985
[TBL] [Abstract][Full Text] [Related]
38. PI(4,5)P2 5-phosphatase A regulates PI3K/Akt signalling and has a tumour suppressive role in human melanoma.
Ye Y; Jin L; Wilmott JS; Hu WL; Yosufi B; Thorne RF; Liu T; Rizos H; Yan XG; Dong L; Tay KH; Tseng HY; Guo ST; de Bock CE; Jiang CC; Wang CY; Wu M; Zhang LJ; Hersey P; Scolyer RA; Zhang XD
Nat Commun; 2013; 4():1508. PubMed ID: 23443536
[TBL] [Abstract][Full Text] [Related]
39. PTEN permits acute increases in D3-phosphoinositide levels following TCR stimulation but inhibits distal signaling events by reducing the basal activity of Akt.
Seminario MC; Precht P; Bunnell SC; Warren SE; Morris CM; Taub D; Wange RL
Eur J Immunol; 2004 Nov; 34(11):3165-75. PubMed ID: 15468057
[TBL] [Abstract][Full Text] [Related]
40. Imatinib mesilate-induced phosphatidylinositol 3-kinase signalling and improved survival in insulin-producing cells: role of Src homology 2-containing inositol 5'-phosphatase interaction with c-Abl.
Mokhtari D; Al-Amin A; Turpaev K; Li T; Idevall-Hagren O; Li J; Wuttke A; Fred RG; Ravassard P; Scharfmann R; Tengholm A; Welsh N
Diabetologia; 2013 Jun; 56(6):1327-38. PubMed ID: 23462796
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]